TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Syra Health Corp. Class A ( (SYRA) ) just unveiled an update.
On November 14, 2025, Syra Health Corp.’s stockholders approved amendments to the company’s Certificate of Incorporation, which included the removal of an automatic conversion clause for Class B Common Stock upon the death of a stockholder and allowed transfers to immediate family members without conversion. The amendments were filed and became effective on November 18, 2025, potentially impacting the company’s stockholder structure and transferability of shares.
Spark’s Take on SYRA Stock
According to Spark, TipRanks’ AI Analyst, SYRA is a Neutral.
The overall stock score is primarily impacted by financial performance challenges, including profitability and cash flow issues, despite strong revenue growth. Technical analysis indicates bearish trends, and valuation metrics are unattractive due to negative earnings. The absence of earnings call insights and corporate events leaves these areas unaddressed.
To see Spark’s full report on SYRA stock, click here.
More about Syra Health Corp. Class A
Average Trading Volume: 22,436
Technical Sentiment Signal: Sell
Current Market Cap: $836.9K
For detailed information about SYRA stock, go to TipRanks’ Stock Analysis page.